Piloting a novel screening tool for reducing heterogeneity in clinical trials in Alzheimer's disease Human/Trial design (2020)
Attributed to:
I-AIM: Individualised Artificial Intelligence for Medicine
funded by
FLF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/alz.046501
Publication URI: http://dx.doi.org/10.1002/alz.046501
Type: Journal Article/Review
Parent Publication: Alzheimer's & Dementia
Issue: S9